C.M. Bidwell & Associates’s Spero Therapeutics SPRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-372	Closed	-$6K	–	603
2021 Q4	$6K	Hold	372	–	–	﹤0.01%	421
2021 Q3	$7K	Hold	372	–	–	﹤0.01%	416
2021 Q2	$5K	Buy	+372	New	+$5K	﹤0.01%	469